Shares of Eli Lilly and Company (NYSE:LLY) surged 12.5% following the announcement of positive Phase 3 trial results for orforglipron, a pioneering oral medication for type 2 diabetes.

President Donald Trump has expressed his dissatisfaction with Federal Reserve Chair Jerome Powell, suggesting that his termination from the position should be expedited. Trump’s comments, shared on ...